February 2025

Heart Failure

Medicines for patients with heart failure with reduced ejection fraction (HFrEF)

This topic covers:

  • Prescribe quadruple therapy for your patients unless contraindicated.

  • Recognise that early initiation and titration of quadruple therapy is the new standard approach to heart failure management, offering rapid and significant improvements in morbidity and mortality.

  • Be aware of the monitoring requirements for patients on quadruple therapy.

  • Ensure you review patients as soon as possible after discharge from hospital and adjust their medications if needed, ideally within seven days.

Recognise that early initiation and titration of quadruple therapy is the new standard approach to heart failure management, offering rapid and significant improvements to morbidity and mortality.

MAIA_Heart-Failure-Therapeutic-Brief_Figure-1-I_FINAL

Up to 7 hours of accredited CPD for GPs

ACRRM_RACGP_TuDk5nq.original

Sign up for email updates from MAIA

We send out occasional updates - no more than once a month.

CPD and resources for pharmacists

MAIA-Consortium-Partner-Logo_PSA-0324-01_WEQ2nx.original

Medicines stewardship resources for service providers

MAIA-Consortium-Partner-Logo_CATAG-0324-01.orig.original_unMljdi

This topic covers:

  • Prescribe quadruple therapy for your patients unless contraindicated.

  • Recognise that early initiation and titration of quadruple therapy is the new standard approach to heart failure management, offering rapid and significant improvements in morbidity and mortality.

  • Be aware of the monitoring requirements for patients on quadruple therapy.

  • Ensure you review patients as soon as possible after discharge from hospital and adjust their medications if needed, ideally within seven days.